Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3092478 | 0.97 | ALDH1A1 (0.49) | ALDH1A1HPGDRAB9ABDKRB2HTT | |
| SCHEMBL1350580 | 0.81 | DNM1 (0.44) | HTTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL3085169 | 0.79 | AKR1C3 (0.42) | ALDH1A1HPGDRAB9AHTTGAA | |
| SCHEMBL28123032 | 0.78 | HSD11B1 (0.42) | HPGDBDKRB2HTTSMN1; SMN2GAA | |
| SCHEMBL4603474 | 0.78 | TRPV1 (0.64) | ALDH1A1HPGDRAB9AMAPTTRPV1 | |
| SCHEMBL28037707 | 0.78 | PLK1 (0.64) | HPGDBDKRB2HTTSMN1; SMN2TRPV1 | |
| SCHEMBL28123631 | 0.78 | DNM1 (0.46) | HTTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL3086075 | 0.78 | ALDH1A1 (0.50) | ALDH1A1HPGDRAB9ABDKRB2HTT | |
| SCHEMBL10523481 | 0.77 | DNM1 (0.44) | HTTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL7083095 | 0.77 | DNM1 (0.44) | HTTSMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2203496-B1 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS | BASF SE (DE) | 2018-04-11 | — | — | EP | disclosed |
| CN-101874050-B | Photolatent catalysts based on organometallic compounds | BASF SE | 2013-10-23 | — | — | CN | disclosed |
| US-8318830-B2 | Photolatent catalysts based on organometallic compounds | BASF SE (DE) | 2012-11-27 | — | — | US | disclosed |
| CN-101874050-A | Photolatent catalysts based on organometallic compound | BASF SE | 2010-10-27 | — | — | CN | disclosed |
| US-20100234485-A1 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS | BASF SE (DE) | 2010-09-16 | — | — | US | disclosed |
| EP-2203496-A1 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS | BASF SE (DE) | 2010-07-07 | — | — | EP | disclosed |
| WO-2009050115-A1 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS | BASF SE (CH) | 2009-04-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234485-A1 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS | PUF60, TST, MPST | ALDH1A1 1432/4885HPGD 1999/4885RAB9A 4001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.